Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.
about
Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreakNosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patientsBacterial evolution in PCD and CF patients follows the same mutational stepsClinical significance of microbial infection and adaptation in cystic fibrosis.Control of Biofilms with the Fatty Acid Signaling Molecule cis-2-Decenoic Acid.Interspecies interaction extends bacterial survival at solid-air interfaces.Infection control in cystic fibrosis.Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan.Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosaCystic fibrosis lung environment and Pseudomonas aeruginosa infection.Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guidelineLongitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosisUse of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative studyDefining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches.Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis.Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
P2860
Q22306482-4EE0CA4D-D87C-4574-8F9D-433BB7BEDFFDQ24658094-CEAE9CC6-CBFB-4ABF-B5AC-120BA710CDC7Q27334684-24480283-B262-4570-920C-AAAD1874F1D5Q34491552-65FB3E38-A8A8-44BD-9C66-02D79DB6EB69Q34503204-47E3E086-10B8-4DA0-BF7D-87D23ACB11CDQ34990917-5B2B70D3-824A-4385-8EB2-8DE24A962713Q35545544-F8C60F6F-A73A-4008-BA64-01648236818EQ35690703-6E8505CD-0A5E-42D8-A52A-AA0ACE9D6EF8Q35834075-5A9784B3-EDC4-4A0B-AF9C-AA68C5DBBBA2Q36213685-1BB17E2B-917D-4125-A285-536A46DAD51AQ36670892-F9E41311-544D-4567-94A1-2F1D03F95A75Q36824415-C0F0F3AB-558B-4782-9B0E-1D4A4202BB4FQ36998768-41A13D76-18E1-498F-9891-7CB8B26692E4Q37162920-1370A7C6-19CA-4DB1-9C5F-79C45EEE240FQ37225824-BCD38717-0EF1-4AF4-B562-DCDBBD7C5912Q37576913-CAEB48F3-840C-48E6-B10C-FE2BB0BCB389Q37775628-A46C28CA-758F-4E87-9BD6-2B63362C635DQ38833703-D0356EBD-425D-473A-98B2-78D770461783Q39097378-C5AA7234-CABA-4816-A9BD-B79B2637588DQ39474739-A39D7B84-9733-4BF1-82C6-EEEE4D1D0694Q42232660-EDA82602-4858-45CF-8977-E0E519442594Q44993011-A3363AF0-4752-4CC9-A1EB-34CB3161FE90Q50546969-4A0580AA-A9C3-4A69-808A-F628393FD33CQ50548290-87F360D3-473F-436B-9E8C-42A85024990EQ51659921-40F13866-920F-410F-9604-7164167137D6Q51669881-3D24FC49-21FE-470B-835D-F1D6D5C225E3
P2860
Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Epidemiology of Pseudomonas ae ...... t in a cystic fibrosis clinic.
@en
type
label
Epidemiology of Pseudomonas ae ...... t in a cystic fibrosis clinic.
@en
prefLabel
Epidemiology of Pseudomonas ae ...... t in a cystic fibrosis clinic.
@en
P2093
P1476
Epidemiology of Pseudomonas ae ...... t in a cystic fibrosis clinic.
@en
P2093
P356
10.1016/0195-6701(83)90062-2
P577
1983-03-01T00:00:00Z